Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 2 Spinal Cord Neoplasms 1 Rhabdoid Tumor 1 Recurrence 1 Prolactinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Diseases 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Medulloblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Large Granular Lymphocytic 1 Familial ependymoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Colorectal Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Choroid Plexus Neoplasms 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1 Bile Duct Neoplasms 1 Astrocytoma 1 Adrenocortical Carcinoma 1 Adrenal Gland Neoplasms 1 Adrenal Cortex Neoplasms 1 Adenoma, Chromophobe 1 Adenoma, Basophil 1 Adenoma, Acidophil 1

Interventions

Mifepristone 3 Corlux 3 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Radiotherapy 1 Radiomics 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 LY2940680 1 Ipilimumab 1 Hydrocortisone 1 Human Growth Hormone 1 Diazoxide 1 Dexmedetomidine 1 Dexamethasone 1 Biomarkers 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pituitary Diseases × Dexamethasone × Endocrine × Clear all

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡